Develops monoclonal antibody therapeutics targeting neurodegenerative and metabolic diseases, focusing on disease-modifying treatments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
TrueBinding Inc. is a clinical-stage biotherapeutic company developing novel monoclonal antibody therapeutics for neurodegenerative and metabolic diseases, stroke, oncology, and other areas with significant unmet medical needs. Their lead candidate, TB006, is a humanized monoclonal antibody targeting Galectin-3, currently under investigation for potential disease-modifying effects in Alzheimer’s and Parkinson’s diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
TrueBinding Management Team
TrueBinding Valuations & Financials
View real-time NPM data on TrueBinding stock including daily TrueBinding stock price estimates, valuation history, and historical share price information. Access TrueBinding financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track TrueBinding pricing across six independent market signals. Looking for private company due diligence data sources on TrueBinding? Get in touch to learn more.
Similar Companies
like TrueBinding
FAQ
We have answers
TrueBinding stock does not trade on public stock exchanges. TrueBinding stock is considered a private security and you need to be an accredited investor to trade shares. To invest in TrueBinding stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
TrueBinding Stock does not trade on public stock exchanges. In order to sell TrueBinding shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
TrueBinding does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view TrueBinding share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for TrueBinding stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell TrueBinding stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in TrueBinding stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
TrueBinding is a private company and has not had an IPO. There is currently no TrueBinding IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to TrueBinding IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
